View on Pubmed.gov 36466873 | View on doi.org 10.3389/fimmu.2...
The immunosuppressive microenvironment and immunotherapy in human glioblastoma.
- Department of Immunology, Binzhou Medical University, Yantai, China.
- Department of Immunology, Qiqihar Medical University, Qiqihar, China.
- Department of Immunology, Harbin Medical University, Harbin, China.
- Department of Neurology, Hongda Hospital, Jinxiang, China.
- School of Medicine, Southern University of Science and Technology, Shenzhen, China.
- School of Computer and Control Engineering, Yantai University, Yantai, China.
Abstract
Glioblastoma multiforme (GBM) is the most malignant intracranial tumor in adults, characterized by extensive infiltrative growth, high vascularization, and resistance to multiple therapeutic approaches. Among the many factors affecting the therapeutic effect, the immunosuppressive GBM microenvironment that is created by cells and associated molecules complex mechanisms plays a particularly important role in facilitating evasion of the tumor from the immune response. Accumulating evidence is also revealing a close association of the gut microbiota with the challenges in the treatment of GBM. The gut microbiota establishes a connection with the central nervous system through bidirectional signals of the gut-brain axis, thus affecting the occurrence and development of GBM. In this review, we discuss the key immunosuppressive components in the tumor microenvironment, along with the regulatory mechanism of the gut microbiota involved in immunity and metabolism in the GBM microenvironment. Lastly, we concentrate on the immunotherapeutic strategies currently under investigation, which hold promise to overcome the hurdles of the immunosuppressive tumor microenvironment and improve the therapeutic outcome for patients with GBM.
References
Trends Cancer. 2022 Oct;8(10):839-854
J Immunother Cancer. 2020 May;8(1):
J Immunol. 2012 Jul 1;189(1):444-53
Brain Pathol. 2010 Jan;20(1):245-54
Cited by 37 citations (total)
Journal Article
Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma.
Electronic publication date January 29, 2025
Junchen Liu [...] Xiaochun Wan et al.
Chimeric antigen receptor T-cell (CAR-T) therapies have shown promise in glioblastoma clinical studies, but responses remain inconsistent due to heterogeneous...
Journal Article
Metagenomics and transcriptomics analysis of aspartame's impact on gut microbiota and glioblastoma progression in a mouse model.
Electronic publication date July 3, 2025
Kaikai Meng [...] Xuanjian Fu et al.
Aspartame, a widely used artificial sweetener, has been extensively studied for its potential health effects. Emerging evidence suggests that aspartame...
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
Substances
- •
Copyright
Copyright © 2022 Zhang, Zhao, Zhang, Zhang, Ju, Wang, Ren, Zhu and Dong.